世界および中国における抗ニューロフィラメントL抗体の市場規模、現状および見通し 2021-2027年Global and China Anti Neurofilament L Antibody Market Size, Status and Forecast 2021-2027 ニューロフィラメントは、軸索の細胞質を支えるニューロンの細胞骨格に必要なフィラメントの一種である。ニューロフィラメントは、軸索にあるフィブリル成分sの中でも最も一般的なタイプである。 市場分析と洞... もっと見る
※当ページの内容はウェブ更新時の情報です。
サマリーニューロフィラメントは、軸索の細胞質を支えるニューロンの細胞骨格に必要なフィラメントの一種である。ニューロフィラメントは、軸索にあるフィブリル成分sの中でも最も一般的なタイプである。市場分析と洞察。抗ニューロフィラメントL抗体の世界市場 抗ニューロフィラメントL抗体の世界市場規模は、2020年のXX百万米ドルから、2021-2027年の間にXX%のCAGRで、2027年にはXX百万米ドルに達すると予測されます。 本レポートは、業界標準の正確な分析と高いデータの整合性により、世界の抗ニューロフィラメントL抗体市場で得られる主要な機会を明らかにし、プレイヤーが市場での確固たる地位を獲得するために役立つ見事な試みを行っています。本レポートの購入者は、収益面での抗ニューロフィラメントL抗体の世界市場全体の規模など、検証済みの信頼できる市場予測にアクセスすることができます。 本レポートは、プレイヤーが競合他社に対して優位に立ち、世界の抗ニューロフィラメントL抗体市場で永続的な成功を収めるための効果的なツールであることを証明しています。本レポートに掲載されているすべての調査結果、データ、情報は、信頼できる情報源の助けを借りて検証、再検証されています。本レポートを執筆したアナリストは、世界の抗ニューロフィラメントL抗体市場を詳細に調査するために、独自の業界最高水準の調査・分析手法を用いています。 世界の抗ニューロフィラメントL抗体の範囲と市場規模 抗ニューロフィラメントL抗体市場は、企業別、地域(国)別、タイプ別、アプリケーション別に分類されています。世界の抗ニューロフィラメントL抗体市場に参加するプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして活用することで、優位に立つことができるでしょう。セグメント別分析では、2016年から2027年の期間におけるタイプ別、アプリケーション別の収益と予測に焦点を当てています。 タイプ別セグメント マウス抗ニューロフィラメントL抗体 ウサギ抗ニューロフィラメントL抗体 その他 用途別セグメント 学術・研究機関 製薬会社、バイオテクノロジー企業 その他 地域別 北アメリカ アメリカ カナダ ヨーロッパ ドイツ フランス イギリス イタリア ロシア 北欧 その他のヨーロッパ諸国 アジア太平洋地域 中国 日本 韓国 東南アジア インド オーストラリア その他のアジア諸国 ラテンアメリカ メキシコ ブラジル その他のラテンアメリカ 中近東・アフリカ トルコ サウジアラビア アラブ首長国連邦 その他の中東・アフリカ地域 会社別 メルク バイオレジェンド セル・シグナリング・テクノロジー ロックランド・イムノケミカルズ バイオ・ラッド・ラボラトリーズ エンコー・バイオテクノロジー 目次1 Report Overview1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Anti Neurofilament L Antibody Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Mouse Anti Neurofilament L Antibody 1.2.3 Rabbit Anti Neurofilament L Antibody 1.2.4 Others 1.3 Market by Application 1.3.1 Global Anti Neurofilament L Antibody Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Academic and Research Institutes 1.3.3 Pharma and Biotech Companies 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Anti Neurofilament L Antibody Market Perspective (2016-2027) 2.2 Anti Neurofilament L Antibody Growth Trends by Regions 2.2.1 Anti Neurofilament L Antibody Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Anti Neurofilament L Antibody Historic Market Share by Regions (2016-2021) 2.2.3 Anti Neurofilament L Antibody Forecasted Market Size by Regions (2022-2027) 2.3 Anti Neurofilament L Antibody Industry Dynamic 2.3.1 Anti Neurofilament L Antibody Market Trends 2.3.2 Anti Neurofilament L Antibody Market Drivers 2.3.3 Anti Neurofilament L Antibody Market Challenges 2.3.4 Anti Neurofilament L Antibody Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Anti Neurofilament L Antibody Players by Revenue 3.1.1 Global Top Anti Neurofilament L Antibody Players by Revenue (2016-2021) 3.1.2 Global Anti Neurofilament L Antibody Revenue Market Share by Players (2016-2021) 3.2 Global Anti Neurofilament L Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Anti Neurofilament L Antibody Revenue 3.4 Global Anti Neurofilament L Antibody Market Concentration Ratio 3.4.1 Global Anti Neurofilament L Antibody Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Anti Neurofilament L Antibody Revenue in 2020 3.5 Anti Neurofilament L Antibody Key Players Head office and Area Served 3.6 Key Players Anti Neurofilament L Antibody Product Solution and Service 3.7 Date of Enter into Anti Neurofilament L Antibody Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Anti Neurofilament L Antibody Breakdown Data by Type 4.1 Global Anti Neurofilament L Antibody Historic Market Size by Type (2016-2021) 4.2 Global Anti Neurofilament L Antibody Forecasted Market Size by Type (2022-2027) 5 Anti Neurofilament L Antibody Breakdown Data by Application 5.1 Global Anti Neurofilament L Antibody Historic Market Size by Application (2016-2021) 5.2 Global Anti Neurofilament L Antibody Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Anti Neurofilament L Antibody Market Size (2016-2027) 6.2 North America Anti Neurofilament L Antibody Market Size by Type 6.2.1 North America Anti Neurofilament L Antibody Market Size by Type (2016-2021) 6.2.2 North America Anti Neurofilament L Antibody Market Size by Type (2022-2027) 6.2.3 North America Anti Neurofilament L Antibody Market Size by Type (2016-2027) 6.3 North America Anti Neurofilament L Antibody Market Size by Application 6.3.1 North America Anti Neurofilament L Antibody Market Size by Application (2016-2021) 6.3.2 North America Anti Neurofilament L Antibody Market Size by Application (2022-2027) 6.3.3 North America Anti Neurofilament L Antibody Market Size by Application (2016-2027) 6.4 North America Anti Neurofilament L Antibody Market Size by Country 6.4.1 North America Anti Neurofilament L Antibody Market Size by Country (2016-2021) 6.4.2 North America Anti Neurofilament L Antibody Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Anti Neurofilament L Antibody Market Size (2016-2027) 7.2 Europe Anti Neurofilament L Antibody Market Size by Type 7.2.1 Europe Anti Neurofilament L Antibody Market Size by Type (2016-2021) 7.2.2 Europe Anti Neurofilament L Antibody Market Size by Type (2022-2027) 7.2.3 Europe Anti Neurofilament L Antibody Market Size by Type (2016-2027) 7.3 Europe Anti Neurofilament L Antibody Market Size by Application 7.3.1 Europe Anti Neurofilament L Antibody Market Size by Application (2016-2021) 7.3.2 Europe Anti Neurofilament L Antibody Market Size by Application (2022-2027) 7.3.3 Europe Anti Neurofilament L Antibody Market Size by Application (2016-2027) 7.4 Europe Anti Neurofilament L Antibody Market Size by Country 7.4.1 Europe Anti Neurofilament L Antibody Market Size by Country (2016-2021) 7.4.2 Europe Anti Neurofilament L Antibody Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Anti Neurofilament L Antibody Market Size (2016-2027) 8.2 Asia-Pacific Anti Neurofilament L Antibody Market Size by Type 8.2.1 Asia-Pacific Anti Neurofilament L Antibody Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Anti Neurofilament L Antibody Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Anti Neurofilament L Antibody Market Size by Type (2016-2027) 8.3 Asia-Pacific Anti Neurofilament L Antibody Market Size by Application 8.3.1 Asia-Pacific Anti Neurofilament L Antibody Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Anti Neurofilament L Antibody Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Anti Neurofilament L Antibody Market Size by Application (2016-2027) 8.4 Asia-Pacific Anti Neurofilament L Antibody Market Size by Region 8.4.1 Asia-Pacific Anti Neurofilament L Antibody Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Anti Neurofilament L Antibody Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Anti Neurofilament L Antibody Market Size (2016-2027) 9.2 Latin America Anti Neurofilament L Antibody Market Size by Type 9.2.1 Latin America Anti Neurofilament L Antibody Market Size by Type (2016-2021) 9.2.2 Latin America Anti Neurofilament L Antibody Market Size by Type (2022-2027) 9.2.3 Latin America Anti Neurofilament L Antibody Market Size by Type (2016-2027) 9.3 Latin America Anti Neurofilament L Antibody Market Size by Application 9.3.1 Latin America Anti Neurofilament L Antibody Market Size by Application (2016-2021) 9.3.2 Latin America Anti Neurofilament L Antibody Market Size by Application (2022-2027) 9.3.3 Latin America Anti Neurofilament L Antibody Market Size by Application (2016-2027) 9.4 Latin America Anti Neurofilament L Antibody Market Size by Country 9.4.1 Latin America Anti Neurofilament L Antibody Market Size by Country (2016-2021) 9.4.2 Latin America Anti Neurofilament L Antibody Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Anti Neurofilament L Antibody Market Size (2016-2027) 10.2 Middle East & Africa Anti Neurofilament L Antibody Market Size by Type 10.2.1 Middle East & Africa Anti Neurofilament L Antibody Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Anti Neurofilament L Antibody Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Anti Neurofilament L Antibody Market Size by Type (2016-2027) 10.3 Middle East & Africa Anti Neurofilament L Antibody Market Size by Application 10.3.1 Middle East & Africa Anti Neurofilament L Antibody Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Anti Neurofilament L Antibody Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Anti Neurofilament L Antibody Market Size by Application (2016-2027) 10.4 Middle East & Africa Anti Neurofilament L Antibody Market Size by Country 10.4.1 Middle East & Africa Anti Neurofilament L Antibody Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Anti Neurofilament L Antibody Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Merck 11.1.1 Merck Company Details 11.1.2 Merck Business Overview 11.1.3 Merck Anti Neurofilament L Antibody Introduction 11.1.4 Merck Revenue in Anti Neurofilament L Antibody Business (2016-2021) 11.1.5 Merck Recent Development 11.2 BioLegend 11.2.1 BioLegend Company Details 11.2.2 BioLegend Business Overview 11.2.3 BioLegend Anti Neurofilament L Antibody Introduction 11.2.4 BioLegend Revenue in Anti Neurofilament L Antibody Business (2016-2021) 11.2.5 BioLegend Recent Development 11.3 Cell Signaling Technology 11.3.1 Cell Signaling Technology Company Details 11.3.2 Cell Signaling Technology Business Overview 11.3.3 Cell Signaling Technology Anti Neurofilament L Antibody Introduction 11.3.4 Cell Signaling Technology Revenue in Anti Neurofilament L Antibody Business (2016-2021) 11.3.5 Cell Signaling Technology Recent Development 11.4 Rockland Immunochemicals 11.4.1 Rockland Immunochemicals Company Details 11.4.2 Rockland Immunochemicals Business Overview 11.4.3 Rockland Immunochemicals Anti Neurofilament L Antibody Introduction 11.4.4 Rockland Immunochemicals Revenue in Anti Neurofilament L Antibody Business (2016-2021) 11.4.5 Rockland Immunochemicals Recent Development 11.5 Bio-Rad Laboratories 11.5.1 Bio-Rad Laboratories Company Details 11.5.2 Bio-Rad Laboratories Business Overview 11.5.3 Bio-Rad Laboratories Anti Neurofilament L Antibody Introduction 11.5.4 Bio-Rad Laboratories Revenue in Anti Neurofilament L Antibody Business (2016-2021) 11.5.5 Bio-Rad Laboratories Recent Development 11.6 EnCor Biotechnology 11.6.1 EnCor Biotechnology Company Details 11.6.2 EnCor Biotechnology Business Overview 11.6.3 EnCor Biotechnology Anti Neurofilament L Antibody Introduction 11.6.4 EnCor Biotechnology Revenue in Anti Neurofilament L Antibody Business (2016-2021) 11.6.5 EnCor Biotechnology Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details
SummaryNeurofilament is a type of filament that is required for the cytoskeleton of a neuron that supports the axon cytoplasm. The neurofilaments are the most common types of fibrillar component s that are available in the axon. Table of Contents1 Report Overview1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Anti Neurofilament L Antibody Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Mouse Anti Neurofilament L Antibody 1.2.3 Rabbit Anti Neurofilament L Antibody 1.2.4 Others 1.3 Market by Application 1.3.1 Global Anti Neurofilament L Antibody Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Academic and Research Institutes 1.3.3 Pharma and Biotech Companies 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Anti Neurofilament L Antibody Market Perspective (2016-2027) 2.2 Anti Neurofilament L Antibody Growth Trends by Regions 2.2.1 Anti Neurofilament L Antibody Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Anti Neurofilament L Antibody Historic Market Share by Regions (2016-2021) 2.2.3 Anti Neurofilament L Antibody Forecasted Market Size by Regions (2022-2027) 2.3 Anti Neurofilament L Antibody Industry Dynamic 2.3.1 Anti Neurofilament L Antibody Market Trends 2.3.2 Anti Neurofilament L Antibody Market Drivers 2.3.3 Anti Neurofilament L Antibody Market Challenges 2.3.4 Anti Neurofilament L Antibody Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Anti Neurofilament L Antibody Players by Revenue 3.1.1 Global Top Anti Neurofilament L Antibody Players by Revenue (2016-2021) 3.1.2 Global Anti Neurofilament L Antibody Revenue Market Share by Players (2016-2021) 3.2 Global Anti Neurofilament L Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Anti Neurofilament L Antibody Revenue 3.4 Global Anti Neurofilament L Antibody Market Concentration Ratio 3.4.1 Global Anti Neurofilament L Antibody Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Anti Neurofilament L Antibody Revenue in 2020 3.5 Anti Neurofilament L Antibody Key Players Head office and Area Served 3.6 Key Players Anti Neurofilament L Antibody Product Solution and Service 3.7 Date of Enter into Anti Neurofilament L Antibody Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Anti Neurofilament L Antibody Breakdown Data by Type 4.1 Global Anti Neurofilament L Antibody Historic Market Size by Type (2016-2021) 4.2 Global Anti Neurofilament L Antibody Forecasted Market Size by Type (2022-2027) 5 Anti Neurofilament L Antibody Breakdown Data by Application 5.1 Global Anti Neurofilament L Antibody Historic Market Size by Application (2016-2021) 5.2 Global Anti Neurofilament L Antibody Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Anti Neurofilament L Antibody Market Size (2016-2027) 6.2 North America Anti Neurofilament L Antibody Market Size by Type 6.2.1 North America Anti Neurofilament L Antibody Market Size by Type (2016-2021) 6.2.2 North America Anti Neurofilament L Antibody Market Size by Type (2022-2027) 6.2.3 North America Anti Neurofilament L Antibody Market Size by Type (2016-2027) 6.3 North America Anti Neurofilament L Antibody Market Size by Application 6.3.1 North America Anti Neurofilament L Antibody Market Size by Application (2016-2021) 6.3.2 North America Anti Neurofilament L Antibody Market Size by Application (2022-2027) 6.3.3 North America Anti Neurofilament L Antibody Market Size by Application (2016-2027) 6.4 North America Anti Neurofilament L Antibody Market Size by Country 6.4.1 North America Anti Neurofilament L Antibody Market Size by Country (2016-2021) 6.4.2 North America Anti Neurofilament L Antibody Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Anti Neurofilament L Antibody Market Size (2016-2027) 7.2 Europe Anti Neurofilament L Antibody Market Size by Type 7.2.1 Europe Anti Neurofilament L Antibody Market Size by Type (2016-2021) 7.2.2 Europe Anti Neurofilament L Antibody Market Size by Type (2022-2027) 7.2.3 Europe Anti Neurofilament L Antibody Market Size by Type (2016-2027) 7.3 Europe Anti Neurofilament L Antibody Market Size by Application 7.3.1 Europe Anti Neurofilament L Antibody Market Size by Application (2016-2021) 7.3.2 Europe Anti Neurofilament L Antibody Market Size by Application (2022-2027) 7.3.3 Europe Anti Neurofilament L Antibody Market Size by Application (2016-2027) 7.4 Europe Anti Neurofilament L Antibody Market Size by Country 7.4.1 Europe Anti Neurofilament L Antibody Market Size by Country (2016-2021) 7.4.2 Europe Anti Neurofilament L Antibody Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Anti Neurofilament L Antibody Market Size (2016-2027) 8.2 Asia-Pacific Anti Neurofilament L Antibody Market Size by Type 8.2.1 Asia-Pacific Anti Neurofilament L Antibody Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Anti Neurofilament L Antibody Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Anti Neurofilament L Antibody Market Size by Type (2016-2027) 8.3 Asia-Pacific Anti Neurofilament L Antibody Market Size by Application 8.3.1 Asia-Pacific Anti Neurofilament L Antibody Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Anti Neurofilament L Antibody Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Anti Neurofilament L Antibody Market Size by Application (2016-2027) 8.4 Asia-Pacific Anti Neurofilament L Antibody Market Size by Region 8.4.1 Asia-Pacific Anti Neurofilament L Antibody Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Anti Neurofilament L Antibody Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Anti Neurofilament L Antibody Market Size (2016-2027) 9.2 Latin America Anti Neurofilament L Antibody Market Size by Type 9.2.1 Latin America Anti Neurofilament L Antibody Market Size by Type (2016-2021) 9.2.2 Latin America Anti Neurofilament L Antibody Market Size by Type (2022-2027) 9.2.3 Latin America Anti Neurofilament L Antibody Market Size by Type (2016-2027) 9.3 Latin America Anti Neurofilament L Antibody Market Size by Application 9.3.1 Latin America Anti Neurofilament L Antibody Market Size by Application (2016-2021) 9.3.2 Latin America Anti Neurofilament L Antibody Market Size by Application (2022-2027) 9.3.3 Latin America Anti Neurofilament L Antibody Market Size by Application (2016-2027) 9.4 Latin America Anti Neurofilament L Antibody Market Size by Country 9.4.1 Latin America Anti Neurofilament L Antibody Market Size by Country (2016-2021) 9.4.2 Latin America Anti Neurofilament L Antibody Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Anti Neurofilament L Antibody Market Size (2016-2027) 10.2 Middle East & Africa Anti Neurofilament L Antibody Market Size by Type 10.2.1 Middle East & Africa Anti Neurofilament L Antibody Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Anti Neurofilament L Antibody Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Anti Neurofilament L Antibody Market Size by Type (2016-2027) 10.3 Middle East & Africa Anti Neurofilament L Antibody Market Size by Application 10.3.1 Middle East & Africa Anti Neurofilament L Antibody Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Anti Neurofilament L Antibody Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Anti Neurofilament L Antibody Market Size by Application (2016-2027) 10.4 Middle East & Africa Anti Neurofilament L Antibody Market Size by Country 10.4.1 Middle East & Africa Anti Neurofilament L Antibody Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Anti Neurofilament L Antibody Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Merck 11.1.1 Merck Company Details 11.1.2 Merck Business Overview 11.1.3 Merck Anti Neurofilament L Antibody Introduction 11.1.4 Merck Revenue in Anti Neurofilament L Antibody Business (2016-2021) 11.1.5 Merck Recent Development 11.2 BioLegend 11.2.1 BioLegend Company Details 11.2.2 BioLegend Business Overview 11.2.3 BioLegend Anti Neurofilament L Antibody Introduction 11.2.4 BioLegend Revenue in Anti Neurofilament L Antibody Business (2016-2021) 11.2.5 BioLegend Recent Development 11.3 Cell Signaling Technology 11.3.1 Cell Signaling Technology Company Details 11.3.2 Cell Signaling Technology Business Overview 11.3.3 Cell Signaling Technology Anti Neurofilament L Antibody Introduction 11.3.4 Cell Signaling Technology Revenue in Anti Neurofilament L Antibody Business (2016-2021) 11.3.5 Cell Signaling Technology Recent Development 11.4 Rockland Immunochemicals 11.4.1 Rockland Immunochemicals Company Details 11.4.2 Rockland Immunochemicals Business Overview 11.4.3 Rockland Immunochemicals Anti Neurofilament L Antibody Introduction 11.4.4 Rockland Immunochemicals Revenue in Anti Neurofilament L Antibody Business (2016-2021) 11.4.5 Rockland Immunochemicals Recent Development 11.5 Bio-Rad Laboratories 11.5.1 Bio-Rad Laboratories Company Details 11.5.2 Bio-Rad Laboratories Business Overview 11.5.3 Bio-Rad Laboratories Anti Neurofilament L Antibody Introduction 11.5.4 Bio-Rad Laboratories Revenue in Anti Neurofilament L Antibody Business (2016-2021) 11.5.5 Bio-Rad Laboratories Recent Development 11.6 EnCor Biotechnology 11.6.1 EnCor Biotechnology Company Details 11.6.2 EnCor Biotechnology Business Overview 11.6.3 EnCor Biotechnology Anti Neurofilament L Antibody Introduction 11.6.4 EnCor Biotechnology Revenue in Anti Neurofilament L Antibody Business (2016-2021) 11.6.5 EnCor Biotechnology Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野の最新刊レポート
QYResearch社のその他分野での最新刊レポート
本レポートと同じKEY WORD(anti)の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/14 10:27 156.77 円 166.04 円 201.95 円 |